Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06487052Recruiting
Catheter-based clot-dissolving drug for intermediate-high risk pulmonary embolism
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
Saint PetersburgAges 18 years+ - NCT07811037RecruitingPhase 1/Phase 2
Safety and effect of SGT003 for advanced solid tumors
This trial tests a new experimental medicine called SGT003 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the medicine is safe, how the body handles it, and whether it can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges 18–75 - NCT07811908RecruitingPhase 2
Testing a new malaria treatment for children
This study tests a new malaria treatment for children with mild (uncomplicated) malaria. The goal is to see if the treatment safely and effectively clears the infection.
BanforaAges 2–12 - NCT07811869RecruitingPhase 3
Remibrutinib for severe itchy skin with unknown cause
This study tests a new medicine called remibrutinib to see if it can reduce severe itching that has no clear cause. It aims to help people whose daily itching is very intense and not relieved by standard creams.
Tampa, FloridaAges 18 years+ - NCT07811193RecruitingPhase 2
Study of new drug combined with immunotherapy for advanced bowel cancer
This trial tests a new drug (VVD-133214) combined with an existing immunotherapy (pembrolizumab) for advanced colorectal cancer that is mismatch repair deficient. It aims to see if the combination works better than pembrolizumab alone in shrinking or controlling the cancer.
Tucson, ArizonaAges 18 years+ - NCT07813234Recruiting
Rib cage reshaping surgery for lower chest prominence
This study tests a surgery to reshape the lower front of the rib cage for people who feel their ribs stick out too much. The surgery uses small plates to hold the new shape. The study will check how well it works and if it improves how people feel about their body.
BogotáAges 18 years+ - NCT06207552RecruitingEarly Phase 1
Gene therapy study for children with Fabry disease
This study tests a new gene therapy for children aged 7 to 17 with Fabry disease. The treatment aims to fix the faulty gene that causes the condition, which may help reduce symptoms and prevent organ damage.
ShanghaiAges 7–18 - NCT07812623Recruiting
SugarVita 2.0 app for type 2 diabetes management
This study tests a mobile app called SugarVita 2.0 that helps you manage your type 2 diabetes. It looks at how easy the app is to use and whether it helps improve blood sugar control over 12 weeks. The app is designed to support you in your daily diabetes care.
Eindhoven, North BrabantAges 18 years+ - NCT07813884Recruiting
Study of a new treatment and blood test for colorectal cancer
This study looks at a new drug that may help treat colorectal cancer, and also tests a blood marker that could help diagnose it. It is for people who are already scheduled to have their colorectal tumor removed with surgery.
NiceAges 18 years+ - NCT07813975Recruiting
Vitamin D for healing bed sores in intensive care
This trial tests whether giving vitamin D supplements through a feeding tube can help heal bed sores (pressure injuries) in intensive care patients. It is for patients who have low vitamin D and early-stage bed sores, and who are otherwise stable enough to participate.
CairoAges 18–60 - NCT07809347Recruiting
Factors linked to slow heart rate after pulsed field ablation
This study looks at why some people have a slower heart rate after a heart procedure called pulmonary vein isolation using pulsed field ablation (PFA). It aims to find out what factors might make this more likely, which could help doctors predict and manage it better.
Wroclaw, Lower Silesian VoivodeshipAges 18 years+ - NCT07812337Recruiting
Blood test guide for Alzheimer's in primary care
This study is testing a tool that helps doctors decide when to order a blood test for Alzheimer's disease. It has two parts: one for doctors and one for older adults without memory problems.
Madison, WisconsinAges 50 years+ - NCT07816887Recruiting
Eye gel changes after cataract surgery
This study looks at how the gel-like fluid inside the eye changes after cataract surgery using special eye scans. It may help doctors understand more about eye health after this common procedure.
Créteil, ParisAges 50 years+ - NCT07814690Recruiting
Choking rescue methods study for adults and children
This study looks at how well different first-aid methods work when someone is choking. If you or your child choked and received help from a bystander or a healthcare provider, this study might help improve future rescue advice.
Calgary, AlbertaAges 3 years+ - NCT07814092Enrolling by invitation
Radiomics for bone health after tooth removal
This trial uses a special imaging technique called radiomics to check how well your jawbone heals after a tooth is removed and the socket is preserved. It may help doctors predict bone quality for future dental implants.
Trieste, TriesteAges 18–75 - NCT07810101Enrolling by invitationPhase 3
Freezing and vitamin C for gum discoloration
This trial tests two treatments for dark spots on the gums: freezing them with liquid nitrogen or applying vitamin C. Both aim to reduce gum discoloration and improve the appearance of your smile.
Asyut, Asyut GovernorateAges 18–40 - NCT07810374Enrolling by invitation
Learning program for swallowing difficulties after stroke
This trial tests an interactive teaching system that helps stroke patients learn about swallowing difficulties (dysphagia). The program uses videos and quizzes to teach you techniques to swallow safely, which might help you recover and avoid complications.
Yuli, Yilan CountyAges 20–75 - NCT07811544Enrolling by invitation
Immune system study for sepsis-related kidney injury after surgery
This study looks at how the immune system responds in patients who develop sepsis after surgery and how it relates to kidney injury. It aims to help improve care for conditions like this.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06494696Recruiting
PSMA PET/MRI with MRI for prostate cancer risk
This study tests whether a special scan (PSMA PET/MRI) combined with a standard MRI can better detect prostate cancer. It is for men who have not had a biopsy yet and are suspected of having prostate cancer.
Taoyuan CityAges 40–85 - NCT06492044Recruiting
Testing right heart strain to predict fluid response in septic shock
This study tests whether measuring the strain (stretch) of the right upper heart chamber with ultrasound can predict if a patient with septic shock will benefit from more fluids. Septic shock is a severe infection that causes very low blood pressure and organ damage.
AmiensAges 18 years+ - NCT06378242RecruitingPhase 1/Phase 2
Testing a bladder cancer drug for high-risk NMIBC patients
This trial tests a drug called Disitamab Vedotin, given directly into the bladder, for a type of early bladder cancer (high-risk NMIBC) that has a protein called HER2. It aims to see if this treatment can help avoid more radical surgery.
Guangzhou, GuangdongAges 18–75 - NCT04805164Recruiting
Gentamicin bone paste to treat stubborn long-bone bone infection
This study tests a bone filler/paste called Cerament-G that releases the antibiotic gentamicin directly at the infected bone site. It aims to improve treatment of chronic bone infection (chronic osteomyelitis) in long bones after surgery.
AmiensAges 18–80 - NCT07802405RecruitingPhase 1
Testing a new drug alone or with ruxolitinib for myelofibrosis
This trial is testing a new drug called WJ01024, which may help treat myelofibrosis. It can be taken alone or with ruxolitinib, a standard treatment for this condition. The study checks safety and how well it works.
Zhengzhou, HenanAges 3 weeks+ - NCT07807163RecruitingPhase 2
Study of ficerafusp alfa with pembrolizumab for head and neck cancer
This study tests a new drug called ficerafusp alfa combined with pembrolizumab (an immunotherapy) in people with head and neck cancer that has returned or spread. The drug targets a protein that may help the immune system fight the cancer. The study is comparing two different schedules of giving the drug to see which is better.
Fort Myers, FloridaAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.